Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data

被引:735
|
作者
Tabrizi, Sarah J. [1 ]
Langbehn, Douglas R. [2 ,3 ]
Leavitt, Blair R. [4 ]
Roos, Raymund A. C. [5 ]
Durr, Alexandra [6 ,7 ]
Craufurd, David [8 ]
Kennard, Christopher [9 ]
Hicks, Stephen L. [9 ]
Fox, Nick C.
Scahill, Rachael I.
Borowsky, Beth [10 ]
Tobin, Allan J. [10 ]
Rosas, H. Diana [11 ]
Johnson, Hans [2 ]
Reilmann, Ralf [12 ]
Landwehrmeyer, Bernhard [13 ]
Stout, Julie C. [14 ,15 ]
机构
[1] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England
[2] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Biostat, Iowa City, IA USA
[4] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
[5] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
[6] Hop La Pitie Salpetriere, APHP, Dept Genet & Cytogenet, Paris, France
[7] Hop La Pitie Salpetriere, APHP, INSERM, UMR 5679, Paris, France
[8] St Marys Hosp, Med Genet Res Grp, Manchester M13 0JH, Lancs, England
[9] Univ Oxford, Dept Clin Neurol, Oxford, England
[10] CHDI Fdn, CHDI Management, New York, NY USA
[11] Harvard Univ, Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA
[12] Univ Munster, Dept Neurol, D-4400 Munster, Germany
[13] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany
[14] Monash Univ, Sch Psychol Psychiat & Psychol Med, Clayton, Vic 3800, Australia
[15] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
来源
LANCET NEUROLOGY | 2009年 / 8卷 / 09期
关键词
AGE-OF-ONSET; TRINUCLEOTIDE REPEAT; PREDICT-HD; DYSFUNCTION; CARRIERS; GENE; NEUROPATHOLOGY; RECOGNITION; DIAGNOSIS; SYMPTOMS;
D O I
10.1016/S1474-4422(09)70170-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Huntington's disease (HD) is an autosomal dominant, fully penetrant, neurodegenerative disease that most commonly affects adults in mid-life. Our aim was to identify sensitive and reliable biomarkers in premanifest carriers of mutated HTT and in individuals with early HD that could provide essential methodology for the assessment of therapeutic interventions. Methods This multicentre study uses an extensive battery of novel assessments, including multi-site 3T MRI, clinical cognitive, quantitative motor, oculomotor, and neuropsychiatric measures. Blinded analyses were done on the baseline cross-sectional data from 366 individuals: 123 controls, 120 premanifest (pre-HD) individuals, and 123 patients with early HD. Findings The first participant was enrolled in January, 2008, and all assessments were completed by August, 2008. Cross-sectional analyses identified significant changes in whole-brain volume, regional grey and white matter differences, impairment in a range of voluntary neurophysiological motor, and oculomotor tasks, and cognitive and neuropsychiatric dysfunction in premanifest HD gene carriers with normal motor scores through to early clinical stage 2 disease. Interpretation We show the feasibility of rapid data acquisition and the use of multi-site 3T MRI and neurophysiological motor measures in a large multicentre study. Our results provide evidence for quantifiable biological and clinical alterations in HTT expansion carriers compared with age-matched controls. Many parameters differ from age-matched controls in a graded fashion and show changes of increasing magnitude across our cohort, who range from about 16 years from predicted disease diagnosis to early HD. These findings might help to define novel quantifiable endpoints and methods for rapid and reliable data acquisition, which could aid the design of therapeutic trials. Funding CHDI/High Q Foundation.
引用
收藏
页码:791 / 801
页数:11
相关论文
共 50 条
  • [21] Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
    Tabrizi, Sarah J.
    Scahill, Rachael I.
    Owen, Gail
    Durr, Alexandra
    Leavitt, Blair R.
    Roos, Raymund A.
    Borowsky, Beth
    Landwehrmeyer, Bernhard
    Frost, Chris
    Johnson, Hans
    Craufurd, David
    Reilmann, Ralf
    Stout, Julie C.
    Langbehn, Douglas R.
    LANCET NEUROLOGY, 2013, 12 (07): : 637 - 649
  • [22] White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis
    Sweidan, Wafaa
    Bao, Fen
    Bozorgzad, Navid-Seraji
    George, Edwin
    JOURNAL OF NEUROIMAGING, 2020, 30 (03) : 351 - 358
  • [23] ROBUST BIOMARKERS OF HUNTINGTON'S DISEASE PROGRESSION: OBSERVATIONS FROM THE TRACK-HD, PREDICT-HD AND IMAGE-HD STUDIES
    Wijeratne, Peter A.
    Johnson, Eileanoir B.
    Gregory, Sarah
    Mohan, Amrita
    Sampaio, Cristina
    Scahill, Rachael I.
    Tabrizi, Sarah J.
    Alexander, Daniel C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 : A47 - A47
  • [24] Occupational performance in Huntington's disease: A cross-sectional study
    Simon-Vicente, Lucia
    Cuesta-Garcia, Cesar
    Rivadeneyra-Posadas, Jessica
    Mariscal, Natividad
    Aguado, Laura
    Miguel-Perez, Irene
    Saiz-Rodriguez, Miriam
    Garcia-Bustillo, Alvaro
    Munoz-Siscart, Ignacio
    Pineiro, Dolores
    Cubo, Esther
    BRITISH JOURNAL OF OCCUPATIONAL THERAPY, 2023, 86 (06) : 432 - 440
  • [25] A 36 MONTH LONGITUDINAL MAGNETIC RESONANCE SPECTROSCOPY STUDY IN PRE-MANIFEST AND EARLY HUNTINGTON DISEASE SUBJECTS FROM THE TRACK-HD STUDY
    Petkau, T.
    Russell-Schulz, B.
    Sturrock, A.
    Hutchinson, J.
    Coleman, A.
    Decolongon, J.
    Hayden, M. R.
    Tabrizi, S. J.
    Mackay, A.
    Leavitt, B. R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 : A48 - A48
  • [26] Cross-sectional and longitudinal multimodal structural imaging in prodromal Huntington's disease
    Harrington, Deborah L.
    Long, Jeffrey D.
    Durgerian, Sally
    Mourany, Lyla
    Koenig, Katherine
    Bonner-Jackson, Aaron
    Paulsen, Jane S.
    Rao, Stephen M.
    MOVEMENT DISORDERS, 2016, 31 (11) : 1664 - 1675
  • [27] Biological and clinical manifestations of juvenile Huntington's disease: a retrospective analysis
    Fusilli, Caterina
    Migliore, Simone
    Mazza, Tommaso
    Consoli, Federica
    De Luca, Alessandro
    Barbagallo, Gaetano
    Ciammola, Andrea
    Mabel Gatto, Emilia
    Cesarini, Martin
    Luis Etcheverry, Jose
    Parisi, Virginia
    Al-Oraimi, Musallam
    Al-Harrasi, Salma
    Al-Salmi, Qasem
    Marano, Massimo
    Vonsattel, Jean-Paul Gerard
    Sabatini, Umberto
    Landwehrmeyer, Georg Bernhard
    Squitieri, Ferdinando
    LANCET NEUROLOGY, 2018, 17 (11): : 986 - 993
  • [28] SPEEDED TAPPING ASSESSES PROGRESSION OF HUNTINGTON'S DISEASE WITHIN ONE YEAR-RESULTS FROM THE TRACK-HD STUDY
    Bechtel, N.
    Acharya, T.
    Sturrock, A.
    Jauffret, C.
    Say, M. J.
    Patel, A.
    Read, J. E.
    t'Hart, E.
    van den Bogaard, S. J. A.
    Duerr, A.
    Leavitt, B. R.
    Roos, R. A. C.
    Langbehn, D. R.
    Tabrizi, S. J.
    Reilmann, R.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 : A27 - A27
  • [29] Altered Cortical Morphometry in Pre-manifest Huntington's Disease: Cross-sectional Data from the IMAGE-HD Study
    Shishegar, Rosita
    Rajapakse, Sudeshna
    Georgiou-Karistianis, Nellie
    2019 41ST ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2019, : 2844 - 2847
  • [30] Psychiatric manifestations in Wilson's disease: A cross-sectional analysis
    Shanmugiah, A.
    Sinha, S.
    Taly, A. B.
    Prashanth, L. K.
    Tomar, M.
    Arunodaya, G. R.
    Reddy, Janardhana Y. C.
    Khanna, S.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2008, 20 (01) : 81 - 85